$2.51T
Total marketcap
$62.64B
Total volume
BTC 50.06%     ETH 16.19%
Dominance

Bio-Rad Laboratories, Inc. BIO-B Stock

338.55 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NYSE
Market Cap
8.76B USD
LOW - HIGH [24H]
338.55 - 338.55 USD
VOLUME [24H]
48 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-21.84 USD

Bio-Rad Laboratories, Inc. Price Chart

Bio-Rad Laboratories, Inc. BIO-B Financial and Trading Overview

Bio-Rad Laboratories, Inc. stock price 338.55 USD
Previous Close 464.1 USD
Open 371.1 USD
Bid 322.23 USD x 1400
Ask 423.08 USD x 800
Day's Range 371.1 - 371.1 USD
52 Week Range 355.36 - 555 USD
Volume 20 USD
Avg. Volume 20 USD
Market Cap 10.97B USD
Beta (5Y Monthly) 0.904225
PE Ratio (TTM) N/A
EPS (TTM) -21.84 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BIO-B Valuation Measures

Enterprise Value 10.52B USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3.9489193
Price/Book (mrq) 1.1253638
Enterprise Value/Revenue 3.785
Enterprise Value/EBITDA 18.934

Trading Information

Bio-Rad Laboratories, Inc. Stock Price History

Beta (5Y Monthly) 0.904225
52-Week Change -20.19%
S&P500 52-Week Change 20.43%
52 Week High 555 USD
52 Week Low 355.36 USD
50-Day Moving Average 416.94 USD
200-Day Moving Average 417.9 USD

BIO-B Share Statistics

Avg. Volume (3 month) 20 USD
Avg. Daily Volume (10-Days) 30 USD
Shares Outstanding 5.07M
Float 21.09M
Short Ratio 0.03
% Held by Insiders 97.39%
% Held by Institutions 0.11%
Shares Short 1
Short % of Float 0%
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -6.88%
Operating Margin (ttm) 14.97%
Gross Margin 55.00%
EBITDA Margin 19.98%

Management Effectiveness

Return on Assets (ttm) 1.85%
Return on Equity (ttm) -1.91%

Income Statement

Revenue (ttm) 2.78B USD
Revenue Per Share (ttm) 93.57 USD
Quarterly Revenue Growth (yoy) -3.30%
Gross Profit (ttm) 1.57B USD
EBITDA 555.52M USD
Net Income Avi to Common (ttm) -191226000 USD
Diluted EPS (ttm) -6.98
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.85B USD
Total Cash Per Share (mrq) 62.53 USD
Total Debt (mrq) 1.38B USD
Total Debt/Equity (mrq) 14.15 USD
Current Ratio (mrq) 5.558
Book Value Per Share (mrq) 329.76

Cash Flow Statement

Operating Cash Flow (ttm) 242.02M USD
Levered Free Cash Flow (ttm) 103.6M USD

Profile of Bio-Rad Laboratories, Inc.

Country United States
State CA
City Hercules
Address 1000 Alfred Nobel Drive
ZIP 94547
Phone 510 724 7000
Website https://www.bio-rad.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 8200

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Q&A For Bio-Rad Laboratories, Inc. Stock

What is a current BIO-B stock price?

Bio-Rad Laboratories, Inc. BIO-B stock price today per share is 338.55 USD.

How to purchase Bio-Rad Laboratories, Inc. stock?

You can buy BIO-B shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bio-Rad Laboratories, Inc.?

The stock symbol or ticker of Bio-Rad Laboratories, Inc. is BIO-B.

Which industry does the Bio-Rad Laboratories, Inc. company belong to?

The Bio-Rad Laboratories, Inc. industry is Medical Devices.

How many shares does Bio-Rad Laboratories, Inc. have in circulation?

The max supply of Bio-Rad Laboratories, Inc. shares is 25.88M.

What is Bio-Rad Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?

Bio-Rad Laboratories, Inc. PE Ratio is now.

What was Bio-Rad Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?

Bio-Rad Laboratories, Inc. EPS is -21.84 USD over the trailing 12 months.

Which sector does the Bio-Rad Laboratories, Inc. company belong to?

The Bio-Rad Laboratories, Inc. sector is Healthcare.

Bio-Rad Laboratories, Inc. BIO-B included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NYSE COMPOSITE (DJ) NYA 17639.04 USD
-1.54